1 episode

Beacon is in partnership with the world’s leading drug development experts to help you keep on top of preclinical and clinical research developments, reviews, trends, landscapes, and more! Join us as the Beacon research team speak to key industry players across various life sciences areas on pressing subjects and key topics. Be sure to subscribe to stay notified of future episodes.

Beacon Brainstorms Beacon Targeted Therapies

    • Science

Beacon is in partnership with the world’s leading drug development experts to help you keep on top of preclinical and clinical research developments, reviews, trends, landscapes, and more! Join us as the Beacon research team speak to key industry players across various life sciences areas on pressing subjects and key topics. Be sure to subscribe to stay notified of future episodes.

    Alessio Ciulli on Drug Design and the Future of TPD

    Alessio Ciulli on Drug Design and the Future of TPD

    Targeted protein degradation (TPD) is an innovative field that is revolutionising drug development, with various modalities being explored by researchers to tackle undruggable targets and treat a wide range of diseases, including cancer, neurological disorders, and skin diseases.
    In this episode, Sofia Rodriguez talks to Alessio Ciulli, professor of chemical structural biology at the University of Dundee and co-founder of Amphista Therapeutics, the leading Europe-based TPD company. Join us to hear about his lab's ground-breaking research into protein degradation, the opening of the new Centre for Targeted Protein Degradation (CeTPD), and the opportunities and challenges of novel degrader design.

    • 23 min

Top Podcasts In Science

Hidden Brain
Alie Ward
Sam Harris
Bloomberg
Neil deGrasse Tyson
Science Friday and WNYC Studios